Innovipharm Ltd in Wirral, CH48 8DA

Description

Data updated on: 01-11-2023

Innovipharm is a company located at CH48 8DA Wirral at 2 Woodlands Lane. This business has been in existence since 2014 and is registered under the registration number 08886792. This business has been actively competing on the British market for ten years now and its last known state is active. This company known today as Innovipharm Ltd, was previously listed as Pharmnovo Uk. The transformation has taken place in 2019-09-05. The company's SIC and NACE codes are 72190: Other research and experimental development on natural sciences and engineering. 2023-03-31 is the last time the company accounts were reported.

At present, there is only one director in the company: David K. (since 2015-01-26). This firm had been supervised by Bengt V. till 2020-10-01. Furthermore, the managing director's responsibilities are helped with by a secretary - Jeanette K., who was chosen by this specific firm on 2015-01-26.

David K. is the individual who controls this firm, owns 1/2 or less of company shares and has 1/2 or less of voting rights.

Previous company's names
Innovipharm Ltd 2019-09-05
Pharmnovo Uk Limited 2014-02-11

Financial data based on annual reports

Profit & Loss
Date of Accounts	2015-02-28	2016-02-29	2017-02-28	2018-02-28	2019-02-28	2020-02-29	2021-02-28	2022-03-31	2023-03-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	100	100

Balance Sheet
Current Assets	100	7 990	2 235	564	1 870	1 021	1 184	151	150
Net Assets Liabilities		100	-3 343	-31 286	-11 025	-13 328	-771	51	150
Debtors	100
Net Assets Liabilities Including Pension Asset Liability	100	100

Capital & Reserves
Called Up Share Capital	100	100
Shareholder Funds	100	100

Other Financial Data
Accrued Liabilities Not Expressed Within Creditors Subtotal		7 890
Average Number Employees During Period						1	1
Creditors			5 578	31 850	12 895	14 349	1 955	100
Net Current Assets Liabilities	100	7 990	-3 343	-31 286	-11 025	-13 328	-771	51	150
Other Operating Expenses Format2		7 377	2 112
Profit Loss			-2 527
Staff Costs Employee Benefits Expense		10 668	11 370
Total Assets Less Current Liabilities	100	7 990	-3 343	-31 286	-11 025	-13 328	-771	51	150
Turnover Revenue		18 045	10 955
Accruals Deferred Income		7 890
Number Shares Allotted	100
Other Operating Charges Format2		7 377
Par Value Share	1
Share Capital Allotted Called Up Paid	100
Staff Costs		10 668
Turnover Gross Operating Revenue		18 045

Company staff

Jeanette K.

Role: Secretary

Appointed: 26 January 2015

Latest update: 16 April 2024

David K.

Role: Director

Appointed: 26 January 2015

Latest update: 16 April 2024

People with significant control

David K.

Notified on 6 April 2016

Nature of control:

1/2 or less of voting rights

right to manage directors

1/2 or less of shares

Bengt V.

Notified on 6 April 2016

Ceased on 1 December 2020

Nature of control:

1/2 or less of voting rights

right to manage directors

1/2 or less of shares

Accounts Documents

Account next due date	31 December 2024
Account last made up date	31 March 2023
Confirmation statement next due date	25 February 2024
Confirmation statement last made up date	11 February 2023

Annual Accounts 13 October 2015
Start Date For Period Covered By Report	2014-02-11
End Date For Period Covered By Report	2015-02-28
Date Approval Accounts	13 October 2015
Annual Accounts 18 October 2016
Start Date For Period Covered By Report	2015-03-01
End Date For Period Covered By Report	2016-02-29
Date Approval Accounts	18 October 2016
Annual Accounts
Start Date For Period Covered By Report	01 March 2016
End Date For Period Covered By Report	28 February 2017
Annual Accounts
Start Date For Period Covered By Report	01 March 2017
End Date For Period Covered By Report	28 February 2018
Annual Accounts
Start Date For Period Covered By Report	01 March 2018
End Date For Period Covered By Report	28 February 2019
Annual Accounts
Start Date For Period Covered By Report	01 March 2019
End Date For Period Covered By Report	29 February 2020
Annual Accounts
Start Date For Period Covered By Report	01 March 2020
End Date For Period Covered By Report	28 February 2021
Annual Accounts
Start Date For Period Covered By Report	01 March 2021
End Date For Period Covered By Report	31 March 2022
Annual Accounts
Start Date For Period Covered By Report	01 April 2022
End Date For Period Covered By Report	31 March 2023

Innovipharm Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Jeanette K.

David K.

Bengt V.

David K.

People with significant control

David K.

Bengt V.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies